Leveraging China to Build a Global Biotech Business

03/28/2013 08:00 a.m. - 11:30 a.m.

Life Sciences + Healthcare and China

12531 High Bluff Drive
Suite 100
San Diego, CA 92130

Steve Rowles

Steve Rowles


Morrison & Foerster and ChinaBio® are pleased to join together to host a workshop for executives and managers of biotechnology and life science companies interested in learning how to leverage China to raise investment funds, develop new drugs or medical devices, and generate global intellectual property rights. The workshop will include sessions on:

Structuring a Global Life Science Company
Relevant structuring considerations to:

  • Enhance financeability by U.S. and China investors
  • Maximize tax efficiency
  • Provide investor-friendly capital structure
  • Preserve flexibility and minimize regulatory approvals for a subsequent liquidity event

Building a Global Patent Portfolio
Secure China, U.S., and international patents to effectively block your competition.

  • Significant changes in the U.S. due to the America
    Invents Act (AIA)
  • Differences between U.S. and China patentability standards
  • U.S. court decisions on patentable subject matter

The State of China's Biotech Industry
China’s life science industry is moving quickly from services to innovation. Hear the latest update on novel technology development, investment, M&A and partnering deals, and other news.


  • Peng Chen, Partner, Morrison & Foerster LLP
  • Steve Rowles, Partner, Morrison & Foerster LLP
  • Greg B. Scott, President & Founder, ChinaBio®

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2019 Morrison & Foerster LLP. All rights reserved.